Table 3 Risk factor associated with the initial prevalence of HCV seropositivity at the six hemodialysis clinics
Risk Factors | N (%) | Anti-HCV + (%) | OR* adjusted (CI95%) | p |
|---|---|---|---|---|
Duration HD* | ||||
Up to 4 years | 278 (64.2) | 9 (3.2) | 1 | - |
Over 4 years | 155 (35.8) | 64 (41.3) | 21.5 (9.7–47.6) | 0.000 |
No. transfusions | ||||
1 – 2 | 150 (41.2) | 20 (13.3) | 1 | - |
3 – 6 | 127 (34.9) | 23 (18.1) | 3.8 (0.9–15.8) | 0.068 |
> 6 | 87 (23.9) | 27 (31.0) | 4.4 (1.0–18.6) | 0.045 |
Clinic groups | ||||
A (4,5,6) | 222 (51.3) | 21 (9.4) | 1 | - |
B (1,2,3) | 211 (48.7) | 52 (24.6) | 4.9 (2.5–9.6) | 0.000 |